By G HossainPosted on September 17, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs In letters to Eli Lilly and Novo Nordisk, the FDA accused the companies of downplaying the risks of their GLP-1 weight loss drugs during a prime time special with Oprah Winfrey. FDA’s Ad Crackdown Targets Novo, Lilly’s Oprah Special on GLP-1s Post navigation FDA Takes Long Overdue Baby Step Toward Regulating Compounder Drug AdsInnate Sheds 30% of Staff, Narrows Pipeline Focus Amid ‘Challenging Funding Environment’